Latest Regulatory News

Lodestar Minerals has appointed two former heavy rare earths experts from MP Materials and Lynas Rare Earths to spearhead its U.S. downstream magnet and supply chain strategy, following its planned acquisition of the Virgin Mountain project in Arizona.

Elixir Energy has independently certified an additional 189 BCFe of 2C contingent gas resources in Queensland’s Taroom Trough, lifting its total certified resources to approximately 2.8 TCFe. This milestone underscores the company’s expanding footprint in a key Australian gas basin with promising commercial potential.

Altech Batteries reveals Sodium-Nickel-Chloride (SNC) batteries achieve an exceptionally low failure rate of 0.6-1.5% over 15+ years in harsh South African conditions, significantly outperforming lithium-ion and lead-acid alternatives.

Arafura Rare Earths secures an ASX waiver allowing eligible shareholders to vote on its upcoming Share Purchase Plan, ensuring broader participation in a key capital raising step.

National Australia Bank reported a 1.2% revenue increase to $20.872 billion in FY25, while net profit dipped 2.9% to $6.759 billion. The bank highlighted progress in customer-centric strategy, technology modernization, and sustainability initiatives.

Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.

Santana Minerals has been granted a 30-year mining permit for its Bendigo-Ophir Gold Project in Central Otago, surpassing earlier expectations of a 25-year term and providing long-term operational certainty.

Verbrec Limited is streamlining its business by selling its Competency Training division for $11.5 million and acquiring Alliance Automation for $5.5 million, significantly boosting its digital and automation capabilities.

Santana Minerals has been granted a crucial 25-year mining permit for its Bendigo-Ophir Gold Project in New Zealand, paving the way for construction and gold production pending environmental approvals.

Nova Eye Medical reported a 20% year-on-year revenue increase in Q1 FY26, reaffirming its FY26 sales guidance and targeting breakeven EBITDA by June 2026 amid cautious commercial expansion.

Mesoblast is set to meet the FDA in December to discuss compelling Phase 3 data showing its cell therapy rexlemestrocel-L may significantly reduce opioid use in chronic low back pain patients. This meeting could mark a pivotal step in addressing the US opioid crisis through innovative regenerative medicine.

RAS Technology Holdings has landed a significant contract to provide racing data and managed trading services for LeoVegas Group’s UK brands, including BetMGM UK, marking a strategic expansion into regulated markets.